Argentyn 23 is a colloidal silver product marketed primarily for immune support, nasal relief, and minor skin care. It contains silver particles suspended in purified water at a concentration of 23 parts per million (ppm), with particles as small as 0.8 nanometers. The manufacturer labels it a “bio-active silver hydrosol” and positions it as a professional-grade supplement, but the FDA has not approved any colloidal silver product for the treatment, prevention, or cure of any disease.
How People Use Argentyn 23
The product is sold in several forms, each aimed at a different application. The liquid version is taken orally, typically held under the tongue for 30 seconds on an empty stomach. Users take it as a daily supplement or increase the frequency during illness. The manufacturer’s suggested use ranges from a small daily dose for general maintenance to more frequent doses (every 20 minutes) during what the label calls “aggressive immune challenges.”
A nasal spray version is marketed for sinus congestion. The manufacturer claims it thins mucus, clears nasal passages of pollutants and irritants, and eases airflow. A topical gel version is sold as a first aid product, positioned to calm minor skin inflammation, reduce topical pain, and support healing of minor skin infections. The gel is labeled as a homeopathic product using the ingredient name Argentum Metallicum.
What the Evidence Actually Shows
Despite widespread marketing claims, no clinical research supports the use of oral colloidal silver for any health condition. The FDA considers colloidal silver products unsafe and ineffective for treating or preventing disease. This isn’t a case of insufficient study. The agency has actively warned consumers and taken enforcement action against companies making therapeutic claims about silver products.
Silver does have genuine antimicrobial properties in laboratory settings. Silver nanoparticles can kill bacteria, and this is why silver is used in some wound dressings and medical devices in hospital settings. But lab activity doesn’t translate directly to what happens inside the human body. Research comparing silver nanoparticles to silver ions in animal models found that nanoparticles showed reduced bacteria-killing ability compared to ionic silver, and were not readily absorbed through respiratory tissue. Very low silver levels were found in the blood after nasal administration, and none was detected in the brain. The antimicrobial effect of silver nanoparticle products appears to come primarily from the small amount of silver that dissolves into ionic form, not from the particles themselves.
A study published in the Journal of Controlled Release specifically noted that products like Argentyn 23 “continue to be marketed today as silver intranasal sprays despite limited evidence for their safety, efficacy, and stability.”
How It Differs From Other Silver Products
The manufacturer distinguishes Argentyn 23 from conventional colloidal silver by emphasizing its smaller particle size and the presence of “bio-active” silver ions. Traditional colloidal silver products vary widely in quality, particle size, and concentration, with some containing much larger particles or higher concentrations. Argentyn 23’s 0.8-nanometer particles are indeed smaller than those in many competing products, which theoretically provides more surface area and greater reactivity.
However, research treats all colloidal silver products as part of the same category of silver nanoparticle suspensions. No published studies demonstrate that “bio-active silver hydrosol” behaves meaningfully differently from other colloidal silver formulations in the human body. The branding distinction is a marketing one, not a clinical one.
Safety Concerns and Exposure Limits
The EPA has established an oral reference dose for silver of 5 micrograms per kilogram of body weight per day. For a 150-pound person, that works out to roughly 340 micrograms daily as the upper boundary considered unlikely to cause harm over a lifetime. Each teaspoon of Argentyn 23 contains about 115 micrograms of silver, meaning even modest daily use can approach or exceed this threshold, especially with the higher doses suggested for acute immune support.
The most well-known risk of excessive silver intake is argyria, a permanent bluish-gray discoloration of the skin caused by silver depositing in tissues. Argyria is cosmetically disfiguring but not life-threatening. It has been documented in people who consumed colloidal silver over extended periods, though cases specifically tied to silver hydrosol products at manufacturer-recommended doses have not been widely reported in the medical literature. The condition is irreversible.
Silver can also interact with certain medications, potentially reducing the absorption of antibiotics and thyroid drugs. Because the body has no biological need for silver, any amount consumed represents an unnecessary exposure with no nutritional upside.
Why It Remains Popular
Argentyn 23 occupies a niche in integrative and naturopathic health circles, where practitioners sometimes recommend it as an alternative to conventional antimicrobials. Its professional branding, low concentration relative to some colloidal silver products, and availability through practitioner channels give it a more clinical appearance than many competitors. User reviews frequently cite perceived benefits for colds, sore throats, sinus infections, and wound healing.
These anecdotal reports are real experiences, but they don’t establish that silver is responsible for improvement. Most acute infections resolve on their own, making it easy to credit whatever supplement someone happened to be taking. Without controlled studies comparing Argentyn 23 to a placebo, there’s no way to separate the product’s effect from the body’s natural recovery.